A. Braghetti

发表

Prospective blinded evaluation of Gd-DOTA- versus Gd-BOPTA-enhanced peripheral MR angiography, as compared with digital subtraction angiography.

L. Cozzi, A. Gallino, S. Gianella, 2003, Radiology.

Lung cancer Presenting as a Metastasis to the Tibial Bones: A Case Report

L. Gurrieri, A. Longhi, A. Braghetti, 2015, Tumori.

Extrahepatic arterioportal fistula: three-dimensional reconstruction of computerized tomodensitometric scan for diagnosis and morphologic assessment

A. Gallino, M. Alerci, A. Braghetti, 2004, Abdominal Imaging.

Ureaplasma and Mycoplasma in kidney allograft recipients—A case series and review of the literature

R. Zbinden, N. Mueller, T. Fehr, 2018, Transplant infectious disease : an official journal of the Transplantation Society.

Middle mesenteric artery: contraindication to endovascular repair of an abdominal aortic aneurysm?

M. Alerci, A. Braghetti, P. Gertsch, 2007, VASA. Zeitschrift fur Gefasskrankheiten.

Pelvimetry by Magnetic Resonance Imaging as a Diagonstic Tool to Evaluate Dystocia

W. Hänggi, P. Vock, S. Spörri, 1997, Obstetrics and gynecology.

Clinical and pharmacological phase I evaluation of Exherin (ADH-1), a selective anti-N-cadherin peptide in patients with N-cadherin-expressing solid tumours.

A. Mancuso, C. Sessa, A. Fasolo, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Laparoscopic Treatment of a Small Bowel Volvulus Secondary to an Uncommon Omphalomesenteric Remnant

M. Mendoza-Sagaon, Y. Hurni, F. Hamitaga, 2017 .

Renal artery assessment with nonenhanced steady-state free precession versus contrast-enhanced MR angiography.

M. Wyss, P. Vock, L. Cozzi, 2007, Radiology.

An enriched phase I, pharmacokinetic and pharmacodynamic study of the N-cadherin (NCAD) cyclic competitive binder exherin (ADH-1) in patients with solid tumors.

C. Sessa, S. Marsoni, A. Fasolo, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I Safety, Pharmacokinetic and Pharmacodynamic Evaluation of the Vascular Disrupting Agent Ombrabulin (AVE8062) in Patients with Advanced Solid Tumors

A. Tolcher, P. LoRusso, J. Soria, 2013, Clinical Cancer Research.

A case of ulceroglandular tularemia presenting with lymphadenopathy and an ulcer on a linear morphoea lesion surrounded by erysipelas

L. Elzi, A. Braghetti, C. Guillod, 2018, International Medical Case Reports Journal.